Early Epigenetic Biomarkers for Perinatal Suicidal Ideation: DNA Methylation Signatures Across the Peripartum Period
genes revealed 1, 10, and 4 significantly differentially methylated probes at each timepoint and implicated genes associated with the hypothalamic-pituitary-adrenal axis. Genome-wide results identified 465, 2,880, and 510 differentially methylated probes and 7, 25, and 12 differentially methylated regions at each timepoint. Pathway analysis at 38-weeks gestation identified vitamin digestion and absorption as the top term differentially methylated in perinatal SI. Additionally, genes implicated in estrogen and oxytocin signaling were also significantly differentially methylated. Post-partum ideation-risk was successfully predicted using the top ten genome-wide differentially methylated probes at 17 weeks (AUC=66.9%), with prediction accuracy highest when DNA methylation and depression severity were combined (AUC=93.2%). Furthermore, the prediction accuracy for identifying novel SI in the post-partum period increased to 86.2% with 17-week biomarkers. Our results deliver novel insights regarding the role of DNA methylation and perinatal SI, with biomarkers providing both mechanistic insights and clinical usefulness, contributing to the field of perinatal psychiatry and epigenetics.
Authors
- Emma Simpson-Wade
- Julien Dubreucq (ORCID: https://orcid.org/0000-0003-4079-4194)
- Joëlle Rüegg (ORCID: https://orcid.org/0000-0002-6580-9201)
- Marie E. Gaine (ORCID: https://orcid.org/0000-0002-9196-0028)
- Alkistis Skalkidou
Institutions
- Uppsala University (SE)
- University of Iowa (US)
- Inserm (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
Publication Details
- Journal
- medRxiv
- Published
- 2026-03-31
- DOI
- https://doi.org/10.64898/2026.03.30.26349727
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Roy J. Carver Charitable Trust
- European Commission
- Vetenskapsrådet
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- National Institutes of Health
- Intellectual and Developmental Disabilities Research Center
- HORIZON EUROPE Framework Programme